Active Biotech AB (publ) (LON:0GQU)

Market Cap	9.12M +34.0%
Revenue (ttm)	n/a
Net Income	-3.04M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,730
Average Volume	296,253
Open	0.04535
Previous Close	n/a
Day's Range	0.04535 - 0.04535
52-Week Range	0.0381 - 0.3290
Beta	1.50
RSI	41.04
Earnings Date	May 7, 2026

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, a mechanism which is in phase 1 for the treatment of severe inflammatory eye diseases, such as non-infectious uveitis; Tasquinimod, an orally active small molecule immunomodulator that blocks tumor-promoting signals in the bone marrow microenvir...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 5
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GQU

Financial Performance

Financial numbers in SEK